UBS Group Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price
CVS Health (NYSE:CVS – Free Report) had its target price lifted by UBS Group from $67.00 to $71.00 in a research note issued to investors on Friday morning,Benzinga reports. The firm currently has a neutral rating on the pharmacy operator’s stock. A number of other analysts also recently weighed in on CVS. Cantor Fitzgerald raised […]
CVS Health (NYSE:CVS – Free Report) had its target price lifted by UBS Group from $67.00 to $71.00 in a research note issued to investors on Friday morning,Benzinga reports. The firm currently has a neutral rating on the pharmacy operator’s stock. A number of other analysts also recently weighed in on CVS. Cantor Fitzgerald raised […]
